Bicycle Therapeutics Cash Flow Statement (2018-2026) | BCYC

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-14.69M-17.98M-27.58M-26.88M-28.39M-32.04M-39.08M-42.60M-49.93M133.84M-26.51M-39.80M-50.80M-51.82M-60.75M-78.98M-59.09M204.45M-60.83M-50.34M
Depreciation and Depletion (Quarter)
0.30M0.40M0.40M0.60M1.30M1.50M1.60M1.60M1.70M1.60M1.70M1.60M
Share-based Compensation (Quarter)
2.69M3.00M10.20M5.67M5.37M5.54M9.04M8.19M7.43M7.81M9.28M9.26M9.20M10.33M9.61M9.44M8.77M-15.41M6.93M6.40M
Deferred Taxes (Quarter)
-0.75M-0.87M-1.02M-2.34M-2.11M-1.58M7.27M-1.07M-0.77M-0.11M-3.31M0.42M-1.32M-0.33M-0.05M0.39M-0.24M0.33M
Gains from Investment Securities (Quarter)
Cash from Operations (Quarter)
21.72M-10.44M-26.40M-23.53M-5.87M-30.31M-46.41M34.10M-1.02M-47.29M-70.87M-44.63M-39.83M-9.40M-86.37M-72.79M-71.17M-19.35M-65.92M-49.61M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.12M0.12M0.14M0.14M0.09M0.08M0.10M0.10M0.09M0.09M0.10M0.11M
Depreciation & Amortization (CF) (Quarter)
0.34M0.41M0.42M0.62M1.26M1.39M1.56M1.65M1.69M1.65M1.66M1.64M2.17M1.70M1.63M1.70M1.76M1.34M1.13M1.07M
Change in Working Capital
Change in Receivables (Quarter)
1.00M-0.99M10.34M-9.69M1.99M-2.52M-49.84M49.88M0.13M
Change in Account Payables (Quarter)
-1.96M0.93M-0.26M1.60M3.59M-2.37M-2.00M2.02M3.81M4.17M-5.92M-0.43M-1.24M10.69M-5.02M6.10M-5.07M-2.88M-3.84M-0.06M
Change in Accured Expenses (Quarter)
0.08M1.71M-2.34M5.55M2.29M6.87M-3.13M11.55M-2.33M-3.69M-5.41M1.79M9.58M3.75M-8.21M9.18M1.12M2.00M-2.35M-0.60M
Other Working Capital Changes (Quarter)
0.16M0.23M0.18M0.16M0.17M-2.62M-1.03M-0.83M2.31M-4.55M0.06M-2.44M2.57M-5.08M-1.29M-1.36M-1.39M-1.41M-1.28M-0.71M
Investing Activities
Capital Expenditures (Quarter)
-0.50M1.73M4.76M9.80M2.98M1.45M2.10M0.28M0.50M0.05M0.01M0.42M0.43M0.37M0.60M0.50M0.67M0.57M0.71M0.27M
Cash from Investing Activities (Quarter)
-0.17M-1.07M-4.76M-9.80M-2.98M-1.45M-2.10M-0.28M-0.50M-0.05M-0.01M-0.42M-0.43M-0.37M-0.60M-0.50M-0.67M-0.57M-0.71M-0.27M
Financing Activities
Other financing activities (Quarter)
3.05M2.27M0.45M0.20M0.16M0.18M0.00M0.17M0.14M0.38M1.87M4.50M0.91M0.24M0.00M0.00M0.00M0.03M0.01M0.00M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
2.18M4.60M2.16M2.89M5.78M5.90M7.30M7.31M7.31M7.47M1.95M6.52M0.10M8.75M0.49M0.61M10.19M9.80M1.69M10.75M
Net Equity Issued and Repurchased (Quarter)
29.84M188.39M2.72M12.10M19.40M0.01M-0.98M
Misc.
Cash from Financing Activities (Quarter)
40.45M190.66M0.45M0.20M0.16M5.89M2.72M12.29M234.63M0.39M1.87M549.61M-31.93M0.20M-0.04M-0.04M-0.03M-0.01M-0.05M-0.05M
Exchange Rate Effect (Quarter)
-1.21M-0.01M-0.60M-1.47M-2.60M3.55M0.45M0.51M-0.90M1.29M-0.42M-0.19M1.70M-1.78M0.47M1.81M-1.25M-0.22M-1.94M-0.05M
Change in Cash (Quarter)
60.79M179.16M-31.31M-34.60M-11.30M-22.32M-45.34M46.62M232.20M-45.66M-69.43M504.37M-70.50M-11.34M-86.55M-71.52M-73.13M-20.16M-68.64M-49.97M
Free Cash Flow (Quarter)
22.21M-12.17M-31.16M-33.33M-8.86M-31.76M-48.51M33.82M-1.53M-47.34M-70.88M-45.05M-40.27M-9.76M-86.97M-73.28M-71.85M-19.92M-66.64M-49.87M
Net Cash Flow (Quarter)
62.00M179.16M-30.71M-33.13M-8.70M-25.87M-45.79M46.11M233.10M-46.95M-69.01M504.56M-72.20M-9.56M-87.02M-73.33M-71.88M-19.93M-66.69M-49.92M